A Novel Cre Recombinase-Mediated in Vivo Minicircle DNA (CRIM) Vaccine Provides Partial Protection Against Newcastle Disease Virus

Applied and Environmental Microbiology - United States
doi 10.1128/aem.00407-19
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

A DNA Vaccine Formulated With Chemical Adjuvant Provides Partial Protection Against Bovine Herpes Virus Infection in Cattle

Frontiers in Immunology
AllergyImmunology
2017English

A Novel Cre Recombinase Imaging System for Tracking Lymphotropic Virus Infection in Vivo

PLoS ONE
Multidisciplinary
2009English

Newcastle Disease Virus-Based Vectored Vaccine Against Poliomyelitis

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2018English

Modified Newcastle Disease Virus as an Improved Vaccine Vector Against Simian Immunodeficiency Virus

Scientific Reports
Multidisciplinary
2018English

Targeted DNA Recombination in Vivo Using an Adenovirus Carrying the Cre Recombinase Gene.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1996English

Efficacy of a Recombinant Genotype VII Vaccine Against Challenge With Velogenic Newcastle Disease Virus

Journal of Vaccines and Immunology
2016English

Genotype-Matched Newcastle Disease Virus Vaccine Confers Improved Protection Against Genotype XII Challenge: The Importance of Cytoplasmic Tails in Viral Replication and Vaccine Design

PLoS ONE
Multidisciplinary
2019English

Single-Dose Replicon Particle Vaccine Provides Complete Protection Against Crimean-Congo Hemorrhagic Fever Virus in Mice

Emerging Microbes and Infections
ImmunologyVirologyMicrobiologyEpidemiologyParasitologyMedicineDrug DiscoveryInfectious Diseases
2019English

Effective Protection Induced by a Monovalent DNA Vaccine Against Dengue Virus (DV) Serotype 1 and a Bivalent DNA Vaccine Against DV1 and DV2 in Mice

Frontiers in Cellular and Infection Microbiology
MedicineInfectious DiseasesImmunologyMicrobiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy